AZD6738 First Time in Patient Multiple Ascending Dose Study

Clinical trial NCT01955668 · COMPLETED

Trial details

NCT number: NCT01955668
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),Prolymphocytic Leukaemia (PLL)B Cell Lymphomas

Start date: 2013-11-01
Primary completion: 2013-12-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.